Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger B Cohen

Showing results (21-30 of 208) with videos related to

Pageof 21
Sort By:
Cancer Management and Research|February 25, 2015
Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinomaOrvar Gunnarsson, Nicklas R Pfanzelter, Roger B Cohen, et al.
JAMA Oncology|March 5, 2016
Cancer Communication in the Social Media AgeMina S Sedrak, Roger B Cohen, Raina M Merchant, et al.
Frontiers in Oncology|March 27, 2026
Recurrent/metastatic relapse after definitive treatment for HNSCC: timing, patterns, and survivalKewen Qu, Margaret Stalker, Wei-Ting Hwang, et al.
European Thyroid Journal|November 1, 2024
Real world outcomes of cabozantinib therapy in poorly differentiated thyroid carcinomaOmar Elghawy, Adam Barsouk, Jessica Xu, et al.
Journal of the Endocrine Society|September 19, 2024
Single-Institution Experience of Larotrectinib Therapy for Patients With <i>NTRK</i> Fusion-Positive Thyroid CarcinomaOmar Elghawy, Adam Barsouk, Alec Heidlauf, et al.
Journal of Cancer Survivorship : Research and Practice|February 15, 2017
Unsupervised exercise in survivors of human papillomavirus related head and neck cancer: how many can go it alone?Joshua Bauml, Jiyoung Kim, Xiaochen Zhang, et al.
Journal of Clinical Pathology|August 29, 2020
Bayesian approach to interpreting somatic cancer sequencing data: a case in pointJu-Yoon Yoon, Jason N Rosenbaum, Norge Vergara, et al.
JAMA Oncology|April 15, 2021
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor-Based Therapy in Patients With Advanced Non-Small-Cell Lung CancerLova Sun, Miles Hsu, Roger B Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2025
"Off-Label" Use of Checkpoint Inhibitors in Patients With Negative or Unknown PD-L1 Status in Advanced Head and Neck CancerMargaret Stalker, Kewen Qu, Roger B Cohen, et al.
Clinical Lung Cancer|November 30, 2024
Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLCMargaret Stalker, Melina Marmarelis, Corey Langer, et al.
Pageof 21

Showing results (21-30 of 208) with videos related to

Sort By:
Pageof 21
Cancer Management and Research|February 25, 2015
Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinomaOrvar Gunnarsson, Nicklas R Pfanzelter, Roger B Cohen, et al.
JAMA Oncology|March 5, 2016
Cancer Communication in the Social Media AgeMina S Sedrak, Roger B Cohen, Raina M Merchant, et al.
Frontiers in Oncology|March 27, 2026
Recurrent/metastatic relapse after definitive treatment for HNSCC: timing, patterns, and survivalKewen Qu, Margaret Stalker, Wei-Ting Hwang, et al.
European Thyroid Journal|November 1, 2024
Real world outcomes of cabozantinib therapy in poorly differentiated thyroid carcinomaOmar Elghawy, Adam Barsouk, Jessica Xu, et al.
Journal of the Endocrine Society|September 19, 2024
Single-Institution Experience of Larotrectinib Therapy for Patients With <i>NTRK</i> Fusion-Positive Thyroid CarcinomaOmar Elghawy, Adam Barsouk, Alec Heidlauf, et al.
Journal of Cancer Survivorship : Research and Practice|February 15, 2017
Unsupervised exercise in survivors of human papillomavirus related head and neck cancer: how many can go it alone?Joshua Bauml, Jiyoung Kim, Xiaochen Zhang, et al.
Journal of Clinical Pathology|August 29, 2020
Bayesian approach to interpreting somatic cancer sequencing data: a case in pointJu-Yoon Yoon, Jason N Rosenbaum, Norge Vergara, et al.
JAMA Oncology|April 15, 2021
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor-Based Therapy in Patients With Advanced Non-Small-Cell Lung CancerLova Sun, Miles Hsu, Roger B Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2025
"Off-Label" Use of Checkpoint Inhibitors in Patients With Negative or Unknown PD-L1 Status in Advanced Head and Neck CancerMargaret Stalker, Kewen Qu, Roger B Cohen, et al.
Clinical Lung Cancer|November 30, 2024
Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLCMargaret Stalker, Melina Marmarelis, Corey Langer, et al.
Pageof 21